Jarno Tuimala Selected Research

Immunoproteins

2/2013	Perinatal immunoproteins predict the risk of cerebral palsy in preterm children.
11/2012	Umbilical artery chemokine CCL16 is associated with preterm preeclampsia and fetal growth restriction.
4/2011	Cord blood chemokines differentiate between spontaneous and elective preterm births in singleton pregnancies.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jarno Tuimala Research Topics

Disease

4	Neoplasms (Cancer) 03/2006 - 04/2002
3	Atherosclerotic Plaque (Atheroma) 01/2021 - 10/2014
3	Hemorrhage 10/2014 - 01/2007
2	Atherosclerosis 01/2022 - 01/2016
2	Stroke (Strokes) 01/2022 - 01/2021
2	Cardiovascular Diseases (Cardiovascular Disease) 12/2021 - 10/2013
2	Inflammation (Inflammations) 01/2016 - 10/2014
2	Premature Birth (Birth, Premature) 04/2015 - 04/2011
2	Chromosome Aberrations (Chromosome Abnormalities) 10/2004 - 06/2004
1	Fatigue 12/2021
1	Mental Fatigue 12/2021
1	COVID-19 12/2021
1	Venous Thrombosis (Deep-Vein Thrombosis) 01/2021
1	Vascular Calcification 01/2021
1	Thromboembolism 01/2021
1	Diseases Newborn Infant 01/2017
1	Coronary Artery Disease (Coronary Atherosclerosis) 01/2016
1	Myocardial Infarction 12/2015
1	Infections 04/2015
1	Carotid Stenosis (Carotid Artery Stenosis) 10/2013
1	Cerebral Palsy (Spastic Diplegia) 02/2013
1	Fetal Growth Retardation (Intrauterine Growth Retardation) 11/2012
1	Pre-Eclampsia (Preeclampsia) 11/2012
1	Premature Obstetric Labor (Premature Labor) 04/2011
1	Burns 09/2009
1	Bronchopulmonary Dysplasia 01/2009
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2009
1	Hereditary leiomyomatosis and renal cell cancer 03/2006
1	Malignant Mesothelioma 04/2002
1	Asbestosis 04/2002

Drug/Important Bio-Agent (IBA)

3	IronIBA 01/2022 - 01/2007
3	ImmunoproteinsIBA 02/2013 - 04/2011
2	Proteins (Proteins, Gene)FDA Link 01/2016 - 01/2009
2	ChemokinesIBA 11/2012 - 04/2011
1	Heme Oxygenase-1IBA 01/2022
1	Messenger RNA (mRNA)IBA 01/2022
1	NexusIBA 01/2022
1	Glutamate-Ammonia Ligase (Glutamine Synthetase)IBA 01/2022
1	Glutamine (L-Glutamine)FDA Link 01/2022
1	ApolipoproteinsIBA 12/2021
1	Apolipoproteins E (ApoE)IBA 12/2021
1	Apolipoprotein E4IBA 12/2021
1	Warfarin (Coumadin)FDA LinkGeneric 01/2021
1	Vitamin K FDA Link 01/2021
1	Intravenous Immunoglobulins (IVIG)FDA Link 01/2017
1	Interleukin-18 (Interleukin 18)IBA 01/2016
1	Mitogen-Activated Protein KinasesIBA 01/2016
1	InflammasomesIBA 01/2016
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 12/2015
1	LipidsIBA 10/2014
1	Heme (Haem)IBA 10/2013
1	HaptoglobinsIBA 10/2013
1	Hemoglobins (Hemoglobin)IBA 10/2013
1	CytokinesIBA 02/2013
1	Caspase 3 (Caspase-3)IBA 10/2011
1	Peptides (Polypeptides)IBA 09/2009
1	Fumarate Hydratase (Fumarase)IBA 03/2006
1	Amino Acids FDA Link 03/2006
1	CarcinogensIBA 10/2004
1	Biomarkers (Surrogate Marker)IBA 10/2004
1	XenobioticsIBA 10/2004
1	EnzymesIBA 10/2004
1	Styrene (Styrol)IBA 06/2004
1	PlasticsIBA 06/2004
1	MutagensIBA 06/2002
1	Bleomycin (Blenoxane)FDA LinkGeneric 06/2002
1	AsbestosIBA 04/2002
1	Superoxide DismutaseIBA 04/2002

Therapy/Procedure

1	Endarterectomy (Thromboendarterectomy) 01/2022
1	Critical Care (Surgical Intensive Care) 12/2021
1	Intrauterine Blood Transfusion 04/2015